BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3840838)

  • 1. Detection of 5-S-cysteinyldopamine in human brain.
    Rosengren E; Linder-Eliasson E; Carlsson A
    J Neural Transm; 1985; 63(3-4):247-53. PubMed ID: 3840838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution and rates of formation of catecholamines in several regions of bovine brain.
    Kindwall EP; Weiner N
    J Neurochem; 1966 Dec; 13(12):1523-31. PubMed ID: 5962032
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dopamine concentration in the nigrostriatal system during electrical stimulation of the head of the caudate nucleus].
    Bazhenova SI; Saul'skaia NB
    Fiziol Zh SSSR Im I M Sechenova; 1979 Apr; 65(4):521-6. PubMed ID: 456666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oxotremorine after nigrostriatal lesions in rats.
    Westermann KH; Oelszner W; Funk KF; Staib AH
    Pol J Pharmacol Pharm; 1975; 27(4):413-7. PubMed ID: 1166022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D-1 receptors in the parkinsonian brain.
    Rinne JO; Rinne JK; Laakso K; Lönnberg P; Rinne UK
    Brain Res; 1985 Dec; 359(1-2):306-10. PubMed ID: 2934111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid.
    Fornstedt B; Bergh I; Rosengren E; Carlsson A
    J Neurochem; 1990 Feb; 54(2):578-86. PubMed ID: 2105377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra.
    Quirion R; Gaudreau P; Martel JC; St-Pierre S; Zamir N
    Brain Res; 1985 Apr; 331(2):358-62. PubMed ID: 2859094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA content and glutamic acid decarboxylase activity in brain of Huntington's chorea patients and control subjects.
    Urquhart N; Perry TL; Hansen S; Kennedy J
    J Neurochem; 1975 May; 24(5):1071-5. PubMed ID: 124764
    [No Abstract]   [Full Text] [Related]  

  • 9. Homovanillic acid in different regions of the human brain: attempt at localizing central dopamine fibres.
    Hornykiewicz O; Lisch HJ; Springer A
    Brain Res; 1968 Dec; 11(3):662-71. PubMed ID: 5712014
    [No Abstract]   [Full Text] [Related]  

  • 10. Regional distribution of the dopamine D2 receptors in the mesotelencephalic dopamine neuron system of human brain.
    De Keyser J; De Backer JP; Ebinger G; Vauquelin G
    J Neurol Sci; 1985 Nov; 71(1):119-27. PubMed ID: 2935593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anterior to posterior variations in the concentration of somatostatin-like immunoreactivity in human basal ganglia.
    Davies P; Josef J; Thompson A
    Brain Res Bull; 1981 Oct; 7(4):365-8. PubMed ID: 6117352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional distribution of gamma-aminobutyric acid (GABA) in brain of the rhesus monkey.
    Fahn S; Côté LJ
    J Neurochem; 1968 Mar; 15(3):209-13. PubMed ID: 4966292
    [No Abstract]   [Full Text] [Related]  

  • 13. [Catecholamines distribution in caudate nucleus, putamen, pallidum and black substance of the rat brain].
    Boissier JR; Portmann EM; Tillement JP
    C R Acad Hebd Seances Acad Sci D; 1973 Jan; 276(1):89-91. PubMed ID: 4196505
    [No Abstract]   [Full Text] [Related]  

  • 14. Light and electron microscopic localization of immunoreactive Leu-enkephalin in the monkey basal ganglia.
    DiFiglia M; Aronin N; Martin JB
    J Neurosci; 1982 Mar; 2(3):303-20. PubMed ID: 6121017
    [No Abstract]   [Full Text] [Related]  

  • 15. Catecholamine topochemistry in human basal ganglia. Comparison between normal and Alzheimer brains.
    Nyberg P; Adolfsson R; Hardy JA; Nordberg A; Wester P; Winblad B
    Brain Res; 1985 Apr; 333(1):139-42. PubMed ID: 3995281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of DARPP-32 in the basal ganglia: an electron microscopic study.
    Ouimet CC; Greengard P
    J Neurocytol; 1990 Feb; 19(1):39-52. PubMed ID: 2191086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Active peptides in substance P preparations from cortex, globus pallidus and substantia nigra of human brains].
    Baldauf J; Harnacke P; Zetler G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):231-41. PubMed ID: 4239251
    [No Abstract]   [Full Text] [Related]  

  • 18. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia.
    Bird ED; Iversen LL
    Brain; 1974 Sep; 97(3):457-72. PubMed ID: 4157009
    [No Abstract]   [Full Text] [Related]  

  • 19. Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species.
    Fornstedt B; Rosengren E; Carlsson A
    Neuropharmacology; 1986 Apr; 25(4):451-4. PubMed ID: 3086766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-correlated loss of dopaminergic binding sites in human basal ganglia.
    Severson JA; Marcusson J; Winblad B; Finch CE
    J Neurochem; 1982 Dec; 39(6):1623-31. PubMed ID: 7142992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.